Viemed Healthcare Celebrates Record Growth in 2023
Company Announcements

Viemed Healthcare Celebrates Record Growth in 2023

Viemed Healthcare US (VMD) has released an update.

Viemed Healthcare reports a triumphant financial year for 2023, achieving record net revenues of $183 million and a net income increase of 65%, marking its seventh consecutive year of growth. The company also celebrated a significant surge in free cash flow and concluded the year with a strong balance sheet, despite taking on some long-term debt from a substantial acquisition. Looking ahead, Viemed anticipates revenues up to $51 million in the first quarter of 2024, independent of Medicare reimbursement rate adjustments.

For further insights into VMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskViemed Healthcare Reports Strong Q3 2024 Performance
TipRanks Canadian Auto-Generated NewsdeskViemed Healthcare Reports Strong Q3 Financial Results
TipRanks Auto-Generated NewsdeskViemed Healthcare Unveils Investor Deck for Stakeholder Insights
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App